DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Amitriptyline Hydrochloride is a drug marketed by Watson Labs, Accord Hlthcare, Am Therap, Ani Pharms, Copley Pharm, Halsey, Lederle, Mankind Pharma, Mutual Pharm, Mylan, Par Pharm, Pliva, Purepac Pharm, Roxane, Sandoz, Sun Pharm Inds Inc, Superpharm, Teva, Ucb Inc, Unichem, Upsher Smith Labs, Usl Pharma, Vangard, Vintage Pharms, West Ward, and Zydus Pharms. and is included in one hundred and sixteen NDAs.
The generic ingredient in AMITRIPTYLINE HYDROCHLORIDE is amitriptyline hydrochloride. There are thirteen drug master file entries for this compound. Thirty-two suppliers are listed for this compound. Additional details are available on the amitriptyline hydrochloride profile page.
A generic version of AMITRIPTYLINE HYDROCHLORIDE was approved as amitriptyline hydrochloride by SUN PHARM INDS INC on July 14th, 1987.
Recent Clinical Trials for AMITRIPTYLINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
|Hospital Israelita Albert Einstein||Phase 4|
|Industria Farmacêutica Health Meds||Phase 4|
|National Institute of Mental Health (NIMH)||Phase 4|
Pharmacology for AMITRIPTYLINE HYDROCHLORIDE
|Drug Class||Tricyclic Antidepressant |